Aquilon Pharma Overview
- Status
- Private
- Employees
- 11

- Latest Deal Type
- Series B
- (In Progress)
- Investors
- 5
Aquilon Pharma General Information
Description
Operator of a pharmaceutical firm intended to develop drugs for the treatment of pulmonary diseases. The company's firm focuses on the development of drugs for the treatment of respiratory disorders and enhances both the lung deposition and the pharmacology of existing drugs for asthma and chronic obstructive pulmonary disease (COPD), enabling patients to get efficient inhalation drugs for respiratory problems.
Contact Information
- 52 Quai De La Boverie
- Walloon Region
- 4020 Liege
- Belgium
Aquilon Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC (Series B) | 00.000 | In Progress | Generating Revenue | |||
3. Early Stage VC | 12-Dec-2018 | 00.00 | 00.000 | Completed | Generating Revenue | |
2. Angel (individual) | 26-Oct-2015 | $388K | $388K | 00000 | Completed | Generating Revenue |
1. Accelerator/Incubator | 14-Nov-2011 | Completed | Generating Revenue |
Aquilon Pharma Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 000 | 00000.00 | 00000.00 | 00 | 00000.00 | 00.000 |
Aquilon Pharma Executive Team (7)
Aquilon Pharma Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Didier Cataldo | Aquilon Pharma | Chairman, Scientific Committee | 000 0000 |
Frank Pieters | Aquilon Pharma | Board Member & Chairman, Strategic Committee | 000 0000 |
Paul Maes | Aquilon Pharma | Chief Executive Officer & Chairman | 000 0000 |
Aquilon Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAquilon Pharma Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Noshaq | Venture Capital | Minority | 000 0000 | 000000 0 | |
SambrInvest | Venture Capital | Minority | 000 0000 | 000000 0 | |
Scale Investment Funds | Venture Capital | Minority | 000 0000 | 000000 0 | |
Be Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
WBC Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |